Seelos Therapeutics
SEEL----
Seelos Therapeutics (SEEL)
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cen...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- IPO Scoop · May 1 at 07:00 AM
The IPO Buzz: Seaport Therapeutics Increases IPO’s Size & Prices it at $18 – Top of Range
- Pharmaceutical Technology · Apr 28 at 05:22 AM
Seaport and Hemab target $180m IPOs as biotech listings accumulate
- MSN · Apr 27 at 08:03 AM
Seaport, Hemab launch US IPOs as biotech listings gather momentum
- RenaissanceCapital · Apr 27 at 08:00 AM
Neuropsychiatric therapeutics Seaport Therapeutics sets terms for $201 million IPO, pricing this week
- Thehill · Apr 22 at 10:05 PM
Trump’s Rogan-inspired psychedelics order stokes cautious optimism
- businessinsider · Apr 11 at 12:32 PM
Neuropsychiatric drug developer Seaport files for U.S. IPO
